Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

155
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
155
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

301
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
301
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

324
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
324
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.5K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.5K
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview01:25

Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview

179
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
179
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

169
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
169

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Huachansu triggers mitochondrial apoptosis and ER stress to inhibit hepatocellular carcinoma progression.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society·2026
Same author

Targeted depolymerization of waste cotton textiles mediated by deep eutectic solvents: High-value recycling of waste cotton textiles into regenerated fibers.

International journal of biological macromolecules·2026
Same author

Global Landscape and Translational Trajectories of Pelvic Floor Muscle Rehabilitation for Urinary Incontinence.

International urogynecology journal·2026
Same author

1q25.3-q32.1 deletion causing multisystem developmental delay: a case report and literature review.

Frontiers in pediatrics·2026
Same author

Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer.

Frontiers in immunology·2026
Same author

Dual-Network Nanocellulose Hydrogels with Dynamic Schiff Base and Borate Bonds for Rapid Self-Healing and Antioxidant Wound Healing.

ACS applied materials & interfaces·2026

Related Experiment Video

Updated: Nov 8, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.0K

An Inductive Logistic Matrix Factorization Model for Predicting Drug-Metabolite Association With Vicus

Yuanyuan Ma1, Lifang Liu2, Qianjun Chen3

  • 1School of Computer and Information Engineering, Anyang Normal University, Anyang, China.

Frontiers in Microbiology
|April 19, 2021
PubMed
Summary

This study introduces a new computational method, inductive logistic matrix factorization (ILMF), to predict drug-metabolite interactions. ILMF effectively identifies potential associations, aiding pharmacomicrobiomics research by overcoming experimental limitations.

Keywords:
Vicus matrixdrug-metabolite associationgraph regularizationhuman metaboliteslogistic matrix factorization

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.0K
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

12.1K

Related Experiment Videos

Last Updated: Nov 8, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.0K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.0K
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

12.1K

Area of Science:

  • Pharmacology
  • Computational Biology
  • Bioinformatics

Background:

  • Metabolites are closely linked to human diseases.
  • Drug-metabolite interactions are crucial in pharmacomicrobiomics but are challenging to study experimentally.
  • Existing computational methods have not extensively predicted large-scale drug-metabolite associations.

Purpose of the Study:

  • To develop a novel algorithm, inductive logistic matrix factorization (ILMF), for predicting latent drug-metabolite associations.
  • To integrate various interaction data (drug-drug, metabolite-metabolite, drug-metabolite) into a unified prediction framework.
  • To leverage inductive matrix completion and fused feature representations for enhanced prediction accuracy.

Main Methods:

  • Proposed the inductive logistic matrix factorization (ILMF) algorithm.
  • Integrated drug-drug, metabolite-metabolite, and drug-metabolite interaction data.
  • Utilized inductive matrix completion with low-dimensional feature representations (F and F) for learning projection matrices (U and V).
  • Employed the Vicus spectral matrix to encode refined local geometrical structures.

Main Results:

  • ILMF demonstrated competitive performance against state-of-the-art approaches.
  • The method effectively predicts potential drug-metabolite associations.
  • Experimental validation was performed on the "DrugMetaboliteAtlas" dataset.

Conclusions:

  • ILMF is an effective computational approach for predicting drug-metabolite associations.
  • The method addresses the limitations of experimental validation in pharmacomicrobiomics.
  • This work contributes to a larger-scale understanding of drug-metabolite interactions.